Foley’s telemedicine report was featured in Nasdaq’s article, “The Healthcare Technology I’m Most Excited About,” on November 16, 2014. The article discussed three trends in the healthcare industry, including telemedicine. Reporter Keith Speights highlighted telemedicine’s potential using Foley survey results, “A survey of healthcare provider executives released by Foley & Lardner LLP found that nine out of 10 have begun implementing a telemedicine program. 84% of the survey respondents said that telemedicine ‘will be central to the success of their organizations.’ That’s not surprising considering the benefits that telemedicine offers.”
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”